AKASA
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $85M
Investors
- 3
About AKASA
Founded in 2018, AKASA Inc. develops AI-driven solutions focused on healthcare revenue cycle management. The company was co-founded by Andy Atwal, Benjamin Beadle-Ryby, Malinka Walaliyadde, and Varun Ganapathi, with Malinka Walaliyadde currently serving as CEO.AKASA provides advanced generative AI solutions specifically tailored for the healthcare revenue cycle. Their core product offerings integrate proprietary generative AI technology with deep revenue cycle management expertise to create impactful solutions that automate complex workflows and empower revenue cycle teams. Key functionalities include a GenAI assistant for prior authorization processes, coding recommendations that enhance comprehensiveness and accuracy, and automated claims status updates that alleviate administrative burdens. The company serves a diverse client base that includes over 650 hospitals and 6,500 outpatient facilities across all 50 states in the United States.AKASA's revenue model is structured around B2B transactions with healthcare organizations, focusing on long-term partnerships to implement their GenAI solutions. Clients typically engage AKASA through subscription contracts that provide access to the company's suite of AI-powered revenue cycle management tools. These subscriptions include various tiers of service, allowing organizations to choose the level of support and features that best fit their operational needs. While specific pricing plans are not disclosed, the offerings are designed to deliver measurable improvements in efficiency and cost reduction, thereby enhancing overall revenue outcomes for healthcare providers.AKASA's strategy for future growth includes the design and launch of new AI products to enhance its offerings, with specific release dates to be announced. The company is also targeting expansion into new geographic regions, with plans to enter additional markets across North America by the end of 2025.
Who invested in AKASA
3 investors across 3 rounds
See all investors in AKASA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AKASA
Who invested in AKASA?
AKASA has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AKASA raised?
AKASA has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did AKASA last raise money?
AKASA's most recent round on record is a Series B, in Mar 2021.
What does AKASA do?
AKASA is a healthcare it company.
Where is AKASA headquartered?
AKASA is headquartered in San Francisco, US.
Which VCs invest in companies like AKASA?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at AKASA's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like AKASA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.